Healthcare provider profile · identity verified

Angela Doddy, CFNP

Nurse Practitioner · SULPHUR SPRINGS, TX · NPI 1801197785

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	313	93
Atorvastatin Calcium	Atorvastatin Calcium	287	88
Gabapentin	Gabapentin	262	66
Levothyroxine Sodium	Levothyroxine Sodium	244	62
Omeprazole	Omeprazole	210	55
Albuterol Sulfate Hfa	Albuterol Sulfate	190	59
Rosuvastatin Calcium	Rosuvastatin Calcium	167	49
Lisinopril	Lisinopril	149	50
Losartan Potassium	Losartan Potassium	148	44
Tizanidine Hcl	Tizanidine Hcl	145	57
Furosemide	Furosemide	134	51
Escitalopram Oxalate	Escitalopram Oxalate	119	32
Metoprolol Succinate	Metoprolol Succinate	104	28
Potassium Chloride	Potassium Chloride	103	38
Carvedilol	Carvedilol	100	29
Pantoprazole Sodium	Pantoprazole Sodium	100	33
Valsartan	Valsartan	98	32
Lovastatin	Lovastatin	92	30
Alendronate Sodium	Alendronate Sodium	89	31
Allopurinol	Allopurinol	86	21
Trazodone Hcl	Trazodone Hcl	86	25
Glipizide Er	Glipizide	85	28
Januvia	Sitagliptin Phosphate	81	22
Lorazepam	Lorazepam	77	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	75	63
Montelukast Sodium	Montelukast Sodium	73	17
Simvastatin	Simvastatin	73	20
Metformin Hcl	Metformin Hcl	72	26
Ozempic	Semaglutide	72	15
Citalopram Hbr	Citalopram Hydrobromide	69	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	15
Trulicity	Dulaglutide	65	12
Hydroxyzine Hcl	Hydroxyzine Hcl	64	12
Triamcinolone Acetonide	Triamcinolone Acetonide	64	33
Metoprolol Tartrate	Metoprolol Tartrate	63	14
Metformin Hcl Er	Metformin Hcl	61	24
Azithromycin	Azithromycin	58	51
Clopidogrel	Clopidogrel Bisulfate	58	20
Fluticasone Propionate	Fluticasone Propionate	58	24
Naproxen	Naproxen	56	21
Eliquis	Apixaban	55	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	55	21
Glimepiride	Glimepiride	53	13
Olmesartan Medoxomil	Olmesartan Medoxomil	49	15
Tamsulosin Hcl	Tamsulosin Hcl	49	18
Lactulose	Lactulose	48	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	37
Tresiba Flextouch U-100	Insulin Degludec	46	15
Levetiracetam	Levetiracetam	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	15
Symbicort	Budesonide/Formoterol Fumarate	43	11
Sertraline Hcl	Sertraline Hcl	42	15
Buspirone Hcl	Buspirone Hcl	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	14
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	12
Meloxicam	Meloxicam	33	suppressed
Tresiba Flextouch U-200	Insulin Degludec	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Amoxicillin	Amoxicillin	28	22
Famotidine	Famotidine	28	suppressed
Cephalexin	Cephalexin	27	26
Vitamin D2	Ergocalciferol (Vitamin D2)	27	11
Glipizide	Glipizide	26	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Fluconazole	Fluconazole	24	17
Linzess	Linaclotide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Doxycycline Hyclate	Doxycycline Hyclate	22	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Estradiol	Estradiol	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Atenolol	Atenolol	16	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nystatin	Nystatin	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Trientine Hcl	Trientine Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error